ALB and Alzheimer disease: A recent interventional trial in septic AD patients reported an 8.3% rate of pulmonary oedema in the albumin treatment group.38 However, the weight based albumin dosing regimen in this study led to much larger daily volumes of albumin being prescribed than suggested in our protocol.